Hiroyoshi Mori

Showing 1-3 of 3 articles

Coronary interventions

Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie F, Virmani R, Finn A

July 19, 2019 | 10.4244/EIJ-D-18-00740

Stents and scaffolds

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

Torii S, Cheng Q, Mori H, Lipinski M, Acampado E, Perkins L, Hossainy S, Pacetti S, Kolodgie F, Virmani R, Finn A

March 20, 2019 | 10.4244/EIJ-D-17-00728

Coronary interventions

Pathological aspects of bioresorbable stent implantation

Sanchez O, Yahagi K, Byrne R, Mori H, Zarpak R, Wittchow E, Foin N, Virmani R, Joner M

May 19, 2015 | 10.4244/EIJV11SVA39

1

Latest news

State-of-the-Art on Glucose Management, Diabetes and PCI; a Mini Focus on CTOs and more...

October 1, 2021

The FAST II study

Kaneshka Masdjedi et al.

October 14, 2021

OCT-guided PCI in iatrogenic artery stenosis

Zvonimir Ostojic et al.

October 14, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair

Mirjam G. Wild et al.

October 14, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.

October 1, 2021

Predictors of rotational atherectomy

Sean Fitzgerald et al.

October 6, 2021

Valvular disease